mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for RNF31
Gene summary
Basic gene Info.Gene symbolRNF31
Gene namering finger protein 31
SynonymsHOIP|ZIBRA
CytomapUCSC genome browser: 14q11.2
Type of geneprotein-coding
RefGenesNM_017999.4,
DescriptionE3 ubiquitin-protein ligase RNF31HOIL-1-interacting proteinzinc in-between-RING-finger ubiquitin-associated domain protein
Modification date20141207
dbXrefs MIM : 612487
HGNC : HGNC
Ensembl : ENSG00000092098
HPRD : 11516
Vega : OTTHUMG00000028798
ProteinUniProt: Q96EP0
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_RNF31
BioGPS: 55072
PathwayNCI Pathway Interaction Database: RNF31
KEGG: RNF31
REACTOME: RNF31
Pathway Commons: RNF31
ContextiHOP: RNF31
ligand binding site mutation search in PubMed: RNF31
UCL Cancer Institute: RNF31
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0000209protein polyubiquitination12629548
GO:0043123positive regulation of I-kappaB kinase/NF-kappaB signaling19136968
GO:0050852T cell receptor signaling pathway20005846
GO:0051092positive regulation of NF-kappaB transcription factor activity19136968
GO:0097039protein linear polyubiquitination21455173


Top
Ligand binding site mutations for RNF31
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H836R837QCOAD1
H923S921YGBM1
C890T891SLUSC1
C817P818LSKCM1
C911K910ISTAD1
G97G97SUCEC1
C986A985VUCEC1
H923,H925G924SUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for RNF31
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C890T891S-1.1620088
C986A985V-1.0786427
H923G924S-0.80579729
H925G924S-0.80579729
G97G97S-0.69201264
H923S921Y-0.64035281
H836R837Q-0.39219003
C911K910I-0.24856136
C817P818L-0.21526133
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for RNF31 from PDB

Top
Differential gene expression and gene-gene network for RNF31
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of RNF31 and the right PPI network was created from samples without mutations in the LBS of RNF31. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for RNF31
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for RNF31
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of RNF31 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)4ljoAC890
ZNZINC(2+)4ljpAC890
ZNZINC(2+)4ljqBC890
ZNZINC(2+)4ljqAC890
ZNZINC(2+)4ljqCC890
ZNZINC(2+)4ljqDC890
ZNZINC(2+)4ljoAC911 H923 H925
ZNZINC(2+)4ljpAC911 H923 H925
ZNZINC(2+)4ljqBC911 H923 H925
ZNZINC(2+)4ljqAC911 H923 H925
ZNZINC(2+)4ljqCC911 H923 H925
ZNZINC(2+)4ljqDC911 H923 H925
ZNZINC(2+)4ljoAC986
ZNZINC(2+)4ljpAC986
ZNZINC(2+)4ljqBC986
ZNZINC(2+)4ljqAC986
ZNZINC(2+)4ljqCC986
ZNZINC(2+)4ljqDC986
IIIPeptide ligand (ASP,LEU,TYR,GLY)4p0aAG97
IIIPeptide ligand (ASP,MET,TYR,ARG)4p0bAG97
IIIPeptide ligand (ASP,MET,TYR,ARG)4p0bCG97
IIIPeptide ligand (GLU,ASP,MET,TYR,ARG,ALA,ALA,ASP,GLU,ILE,GLU,LYS,GLU)4oykAG97
IIIPeptide ligand (GLU,ASP,MET,TYR,ARG,ALA,ALA,ASP,GLU,ILE,GLU,LYS,GLU,LYS,GLU)4oykBG97


Top
Conservation information for LBS of RNF31
Multiple alignments for Q96EP0 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas